TW332814B - Morphinan derivative - Google Patents

Morphinan derivative

Info

Publication number
TW332814B
TW332814B TW082100590A TW82100590A TW332814B TW 332814 B TW332814 B TW 332814B TW 082100590 A TW082100590 A TW 082100590A TW 82100590 A TW82100590 A TW 82100590A TW 332814 B TW332814 B TW 332814B
Authority
TW
Taiwan
Prior art keywords
agents
diuretic
analgesic
morphinan derivative
derivative
Prior art date
Application number
TW082100590A
Other languages
English (en)
Inventor
Hiroshi Nagase
Takaharu Kawai
Kuniaki Kawamura
Jun Hayakawa
Takashi Endou
Original Assignee
Toray Industries
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Toray Industries filed Critical Toray Industries
Application granted granted Critical
Publication of TW332814B publication Critical patent/TW332814B/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D489/00—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
    • C07D489/06—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: with a hetero atom directly attached in position 14
    • C07D489/08—Oxygen atom

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Inorganic Compounds Of Heavy Metals (AREA)
  • Fertilizers (AREA)
  • Saccharide Compounds (AREA)
TW082100590A 1992-01-23 1993-01-30 Morphinan derivative TW332814B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP1011592 1992-01-23
JP29430892 1992-11-02

Publications (1)

Publication Number Publication Date
TW332814B true TW332814B (en) 1998-06-01

Family

ID=26345314

Family Applications (1)

Application Number Title Priority Date Filing Date
TW082100590A TW332814B (en) 1992-01-23 1993-01-30 Morphinan derivative

Country Status (15)

Country Link
US (2) US6323212B1 (zh)
EP (2) EP0846694A1 (zh)
JP (1) JP2525552B2 (zh)
KR (1) KR970011390B1 (zh)
AT (1) ATE172201T1 (zh)
AU (2) AU666702B2 (zh)
CA (1) CA2105072C (zh)
DE (1) DE69321525T2 (zh)
DK (1) DK0577847T3 (zh)
ES (1) ES2121988T3 (zh)
FI (1) FI106126B (zh)
NO (1) NO302755B1 (zh)
NZ (1) NZ246687A (zh)
TW (1) TW332814B (zh)
WO (1) WO1993015081A1 (zh)

Families Citing this family (79)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2121988T3 (es) 1992-01-23 1998-12-16 Toray Industries Derivado de morfinano y uso medicinal.
AU683664B2 (en) * 1993-06-30 1997-11-20 Toray Industries, Inc. Antitussive
DE69414085T2 (de) * 1993-07-19 1999-03-18 Toray Industries, Inc., Tokio/Tokyo Wirkstoff zum schutze von gehirnzellen
WO1995003308A1 (en) * 1993-07-23 1995-02-02 Toray Industries, Inc. Morphinan derivative and medicinal use
SE9401727D0 (sv) * 1994-05-18 1994-05-18 Astra Ab New compounds I
DE19602964A1 (de) * 1995-12-20 1997-07-31 Nycomed Arzneimittel Gmbh Neue Morphinderivate, Verfahren zu deren Herstellung und deren Verwendung
US6239154B1 (en) 1996-03-08 2001-05-29 Adolor Corporation Kappa agonist compounds pharmaceutical formulations and method of prevention and treatment of pruritus therewith
US5763445A (en) 1996-03-08 1998-06-09 Adolor Corporation Kappa agonist compounds pharmaceutical formulations and method of prevention and treatment of pruritus therewith
EP0829481A1 (en) * 1996-09-16 1998-03-18 Pfizer Inc. Morphinan hydroxamic acid compounds
ES2236630T3 (es) * 1996-11-25 2005-07-16 Toray Industries, Inc. Agente antipruritico.
DE69838662T2 (de) 1997-03-27 2008-08-28 Toray Industries, Inc. Morphinanderivate und ihre medizinische Anwendung
ES2217563T3 (es) 1997-07-11 2004-11-01 Toray Industries, Inc. Compuestos medicinales estables que contienen derivados de 4,5-epoximorfinado.
US5760023A (en) * 1997-07-14 1998-06-02 Adolor Corporation Kappa agonist anti-pruritic pharmaceutical formulations and method of treating pruritus therewith
NZ500438A (en) * 1997-07-14 2001-11-30 Adolor Corp Compositions containing a compound having kappa opioid agonist activity for treatment of pruritis (itchiness)
AU6117298A (en) * 1997-07-25 1999-02-16 Toray Industries, Inc. Hyponatremia remedies
CA2270955C (en) * 1997-09-02 2007-08-07 Toray Industries Inc. Pharmaceutical composition containing morphinan derivative for treating drug dependence
US6083944A (en) * 1997-10-07 2000-07-04 Cephalon, Inc. Quinoline-containing α-ketoamide cysteine and serine protease inhibitors
TW570920B (en) * 1998-12-22 2004-01-11 Janssen Pharmaceutica Nv 4-(aminomethyl)-piperidine benzamides for treating gastrointestinal disorders
CN1204139C (zh) * 1999-08-24 2005-06-01 东丽株式会社 神经性疼痛治疗剂
US6688746B2 (en) * 1999-12-03 2004-02-10 Iouri Malov Field testing using spread spectrum technique
WO2001074819A1 (fr) * 2000-04-03 2001-10-11 Toray Industries, Inc. Agents analgesiques contenant des derives de n-oxyde de morphinane en tant que principe actif
CN100398154C (zh) 2001-03-30 2008-07-02 东丽株式会社 精神神经疾病治疗药
WO2002080918A1 (fr) * 2001-04-02 2002-10-17 Toray Industries, Inc. Agent therapeutique ou prophylactique en cas de miction frequente ou d'incontinence urinaire
DE10161963A1 (de) * 2001-12-17 2003-07-03 Johannes Schuetz 6-Aminomorphinanderivate, Herstellungsverfahren dafür und deren Verwendung
EP1506174B1 (en) 2002-05-17 2015-09-30 Taiwanj Pharmaceuticals Co., Ltd. Use of naltrexone for treating kidney and liver damage
US7501433B2 (en) * 2002-05-17 2009-03-10 Jenken Biosciences, Inc. Opioid and opioid-like compounds and uses thereof
US7923454B2 (en) * 2002-05-17 2011-04-12 Jenken Biosciences, Inc. Opioid and opioid-like compounds and uses thereof
JP4016986B2 (ja) 2002-10-09 2007-12-05 東レ株式会社 頻尿もしくは尿失禁の治療または予防剤および含窒素環状置換基を有するモルヒナン誘導体
US8017622B2 (en) 2003-05-16 2011-09-13 Jenken Biosciences, Inc. Opioid and opioid-like compounds and uses thereof
CA2527693C (en) * 2003-06-04 2018-09-18 Harry G. Brittain Polymorphic forms of naltrexone
DK1758452T3 (en) * 2004-05-28 2017-05-01 Human Biomolecular Res Inst METABOLIC STABLE ANALGETICS AND Painkillers
TW200621785A (en) * 2004-11-04 2006-07-01 Toray Industries Analgesic
NZ563133A (en) * 2005-04-06 2010-07-30 Toray Industries Crystals of morphinan derivative and process for producing the same
ES2307352B1 (es) * 2005-04-12 2009-09-18 Bti, I+D, S.L. Implante dental y piezas destinadas a ser conectadas a un implante dental, y la conexion interna entre el implante dental y cada pieza.
EP2010539B1 (en) * 2006-04-21 2017-06-14 Nektar Therapeutics Stereoselective reduction of a morphinone
EP2151240B1 (en) 2007-04-24 2013-06-12 Toray Industries, Inc. Therapeutic or prophylactic agent for dyskinesia
CN101686976B (zh) 2007-04-26 2013-04-24 东丽株式会社 含有4,5-环氧基吗啡喃衍生物的稳定的固体制剂
CN101778632B (zh) 2007-06-22 2012-02-29 东丽株式会社 综合失调症的治疗或预防药
BRPI0817804A8 (pt) 2007-10-05 2017-04-18 Toray Industries Agente terapêutico para melhorar as propriedades da pele compreendendo um derivado de morfinano ou qualquer um de seus sais de adição de ácido farmacologicamente permissíveis como um ingrediente ativo
ES2671897T3 (es) * 2008-02-14 2018-06-11 Alkermes, Inc. Compuestos opioides selectivos
WO2010006299A1 (en) * 2008-07-11 2010-01-14 Regents Of The University Of Minnesota Analgesic agents
JP5648480B2 (ja) 2008-10-24 2015-01-07 東レ株式会社 ４，５−エポキシモルヒナン誘導体を含有する安定な錠剤
EP2398805A1 (en) * 2009-02-23 2011-12-28 Mallinckrodt LLC (+)-morphinanium quaternary salts and processes for their production
US8946419B2 (en) 2009-02-23 2015-02-03 Mallinckrodt Llc (+)-6-hydroxy-morphinan or (+)-6-amino-morphinan derivatives
US8563727B2 (en) * 2009-02-23 2013-10-22 Mallinckrodt Llc (+)-morphinanium N-oxides and processes for their production
WO2010096791A1 (en) * 2009-02-23 2010-08-26 Mallinckrodt Inc. (+)-6-hydroxy-morphinan or (+)-6-amino-morphinan derivatives
WO2010144641A1 (en) * 2009-06-11 2010-12-16 Mallinckrodt Inc. Preparation of 6-alpha-amino n-substituted morphinans by catalytic hydrogen transfer
EP2440561B1 (en) * 2009-06-11 2014-04-30 Mallinckrodt LLC Reductive amination of 6-keto normorphinans by catalytic hydrogen transfer
WO2011009020A2 (en) 2009-07-16 2011-01-20 Mallinckrodt Inc. Compounds and compositions for use in phototherapy and in treatment of ocular neovascular disease and cancers
US10363251B2 (en) 2009-07-16 2019-07-30 Mallinckrodt Llc (+)-morphinans as antagonists of toll-like receptor 9 and therapeutic uses thereof
MX362830B (es) 2010-01-29 2019-02-14 Toray Industries Agente terapeutico o profilactico para enfermedades del tracto biliar.
ES2645725T3 (es) 2010-06-11 2017-12-07 Rhodes Technologies Procesos catalizados por metales de transición para la preparación de compuestos de N-alilo y uso de los mismos
EP2580218B1 (en) 2010-06-11 2015-02-25 Rhodes Technologies Process for n-dealkylation of tertiary amines
CA2768199C (en) 2010-07-16 2018-08-28 Mallinckrodt Llc (+)-morphinans as antagonists of toll-like receptor 9 and therapeutic uses thereof
JP6013345B2 (ja) * 2010-10-19 2016-10-25 メモリアル スローン−ケタリング キャンサー センター 痛み治療用の４，５ａ−エポキシモルフィナンの６−アミド誘導体
CN103327977B (zh) 2011-01-31 2016-05-04 东丽株式会社 恶液质的治疗或预防剂
MX2013013634A (es) 2011-06-09 2013-12-12 Mallinckrodt Llc Aminacion reductiva de 6-ceto-morfinanos por transfrencia catalitica de hidrogeno.
ES2566620T3 (es) 2011-09-08 2016-04-14 Mallinckrodt Llc Procesamiento de alcaloides sin el aislamiento de intermedios
DK2884978T3 (da) 2012-08-16 2019-09-30 Scripps Research Inst Nye Kappa-opioidligander
TWI449704B (zh) * 2013-04-26 2014-08-21 Everlight Chem Ind Corp 嗎啡喃衍生物之結晶、其製造方法、及使用其之醫藥組成物
WO2015082932A1 (en) 2013-12-05 2015-06-11 The University Of Bath Novel opioid compounds and their uses
JP2015166331A (ja) * 2014-05-14 2015-09-24 遼東化学工業株式会社 ナルフラフィンの結晶およびその製造方法
WO2016152953A1 (ja) * 2015-03-24 2016-09-29 東レ株式会社 モルヒナン誘導体及びその医薬用途
EP4212532A3 (en) 2015-04-30 2023-09-27 Memorial Sloan Kettering Cancer Center Mitragynine analogs and uses thereof
AU2016346558A1 (en) 2015-10-29 2018-04-26 University Of Tsukuba Morphinan derivative and medical usage thereof
JP2019509321A (ja) 2016-03-22 2019-04-04 リージェンツ オブ ザ ユニバーシティ オブ ミネソタ 疼痛を処置するための組み合わせ
EP3458061B1 (en) * 2016-05-19 2023-01-18 Virginia Commonwealth University Potent and selective mu opioid receptor modulators
JP6814470B2 (ja) 2017-02-10 2021-01-20 国立大学法人 筑波大学 モルヒナン誘導体
WO2019168985A1 (en) * 2018-02-27 2019-09-06 Delpor, Inc. Compositions for small molecule therapeutic agent compounds
EP3761982B1 (en) 2018-03-08 2024-10-09 Victoria Link Ltd Use of nalfurafine for the treatment of demyelinating diseases
US11214577B2 (en) * 2019-03-29 2022-01-04 Humanwell Pharmaceutical US Morphinans useful for treating medical disorders
CA3146163A1 (en) * 2019-07-08 2021-01-14 University Of Health Sciences & Pharmacy In St. Louis G-protein biased opioid receptor agonist/analgesics with reduced arrestin recruitment
KR20220071223A (ko) 2019-09-30 2022-05-31 닛뽕 케미파 가부시키가이샤 아제판 유도체
EP4049658A4 (en) 2019-10-24 2023-11-22 Toray Industries, Inc. THERAPEUTIC OR PROPHYLACTIC AGENT AGAINST CACHEXIA
TW202216145A (zh) 2020-06-30 2022-05-01 日商東麗股份有限公司 伴隨代謝異常之疾病或症候群中的肌力低下症狀之改善劑或預防劑
CN115181109B (zh) * 2021-04-02 2024-06-04 南京正大天晴制药有限公司 吗啡喃衍生物的晶体及其制备方法
AU2022260191A1 (en) 2021-04-23 2023-10-26 Toray Industries, Inc. Therapeutic or prophylactic agent for cachexia accompanied by ghrelin resistance
IL309232A (en) 2021-06-14 2024-02-01 Scorpion Therapeutics Inc History of urea which can be used to treat cancer
WO2023190665A1 (ja) * 2022-03-29 2023-10-05 東レ株式会社 モルヒナン誘導体及びその医薬用途

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL290054A (zh) *
US3236851A (en) * 1966-02-22 Unsaturated morphinan derivatives
DE622231C (de) * 1934-03-09 1935-11-23 Hermann Fischer Dr Verfahren zur Herstellung von Diacetylmorphin
GB864107A (en) 1958-09-10 1961-03-29 Albert Boehringer Morphine derivatives
GB919311A (en) * 1958-10-29 1963-02-20 T & H Smith Ltd Derivatives of 14-hydroxycodeine and their preparation
DE2254298A1 (de) * 1972-11-06 1974-05-16 Boehringer Sohn Ingelheim Neue (heteroarylmethyl)-normorphine, deren saeureadditionssalze, verfahren zu deren herstellung sowie deren verwendung als arzneimittel
GB1587831A (en) * 1977-03-23 1981-04-08 Reckitt & Colmann Prod Ltd Morphine derivatives
GB1593191A (en) 1977-03-23 1981-07-15 Reckitt & Colmann Prod Ltd Derivatives of morphine
US4362870A (en) * 1980-01-16 1982-12-07 Regents Of The University Of Minnesota Selective opioid receptor alkylating agents
JPS574991A (en) 1980-06-10 1982-01-11 Sankyo Co Ltd Cyclopropylmethylnormorphine-6-sulfuric ester
US4401672A (en) 1981-10-13 1983-08-30 Regents Of The University Of Minnesota Non-addictive narcotic antitussive preparation
US4668685A (en) * 1984-07-05 1987-05-26 E.I. Du Pont De Nemours And Company Substituted benzoate ester prodrug derivatives of 3-hydroxymorphinans, which are analgesics or narcotic antagonists
US4767718A (en) * 1984-06-18 1988-08-30 Southern Illinois University Foundation Fluorescent opioid reagents and methods of use thereof in the detection of opioid receptors
IN163125B (zh) 1985-01-08 1988-08-13 Alkaloida Vegyeszeti Gyar
HU196376B (en) * 1985-05-23 1988-11-28 Sandoz Ag Process for preparing morphinane derivatives and pharmaceutical compositions containing such compounds
DE3617182A1 (de) 1985-05-23 1986-11-27 Sandoz-Patent-GmbH, 79539 Lörrach Morphinan-derivate
US4730048A (en) 1985-12-12 1988-03-08 Regents Of The University Of Minnesota Gut-selective opiates
US4806556A (en) 1985-12-12 1989-02-21 Regents Of The University Of Minnesota Gut-selective opiates
US4673679A (en) * 1986-05-14 1987-06-16 E. I. Du Pont De Nemours And Company Use of prodrugs of 3-hydroxymorphinans to prevent bitter taste upon buccal, nasal or sublingual administration
US4816586A (en) * 1987-07-29 1989-03-28 Regents Of The University Of Minnesota Delta opioid receptor antagonists
JPH01149788A (ja) 1987-12-08 1989-06-12 Chugai Pharmaceut Co Ltd 新規なモルヒネ誘導体
FR2636330B1 (fr) 1988-09-13 1990-11-30 Sanofi Sa Procede de preparation de derives de morphinane
US5219861A (en) * 1988-12-21 1993-06-15 Chugai Seiyaku Kabushiki Kaisha 6 β-Thiomorphine derivatives
KR900009650A (ko) * 1988-12-21 1990-07-05 사노하지메 신규 모르핀 유도체
US5258386A (en) * 1991-06-05 1993-11-02 The United States Of America As Represented By The Secretary Of The Army (+)-3-substituted-N alkylmorphinans, synthesis and use as anticonvulsant and neuroprotective agents
ES2121988T3 (es) * 1992-01-23 1998-12-16 Toray Industries Derivado de morfinano y uso medicinal.
AU683664B2 (en) * 1993-06-30 1997-11-20 Toray Industries, Inc. Antitussive

Also Published As

Publication number Publication date
DK0577847T3 (da) 1999-06-23
ATE172201T1 (de) 1998-10-15
FI106126B (fi) 2000-11-30
DE69321525T2 (de) 1999-03-04
NZ246687A (en) 1996-12-20
US6277859B1 (en) 2001-08-21
US6323212B1 (en) 2001-11-27
EP0577847A1 (en) 1994-01-12
KR970011390B1 (ko) 1997-07-10
AU4067195A (en) 1996-03-07
EP0577847B1 (en) 1998-10-14
CA2105072A1 (en) 1993-07-24
FI934144A0 (fi) 1993-09-22
ES2121988T3 (es) 1998-12-16
WO1993015081A1 (fr) 1993-08-05
NO933376D0 (no) 1993-09-22
NO933376L (no) 1993-09-23
JP2525552B2 (ja) 1996-08-21
EP0577847A4 (en) 1994-12-07
AU686483B2 (en) 1998-02-05
AU666702B2 (en) 1996-02-22
AU3367193A (en) 1993-09-01
CA2105072C (en) 1998-07-28
FI934144A (fi) 1993-09-22
DE69321525D1 (de) 1998-11-19
JPH08502275A (ja) 1996-03-12
EP0846694A1 (en) 1998-06-10
NO302755B1 (no) 1998-04-20

Similar Documents

Publication Publication Date Title
TW332814B (en) Morphinan derivative
CA2143864A1 (en) Morphinan derivatives and pharmaceutical use thereof
CA2382919A1 (en) Bicyclic imidazo-3-yl-amine derivatives
HUT62290A (en) Process for producing imidazole derivatives substituted with aromatic group, as well as pharmaceutical compositions comprising same as active ingredient
AU6522090A (en) Bicyclic pyrimidine derivative, method of producing the same, and pharmaceutical preparation containing the same as active ingredient
NO964871L (no) Nye agonistforbindelser
GEP20053476B (en) 3(5)-Amino-Pyrazole Derivatives, Process for Their Preparation and Their Use as Antitumor Agents
HUT49612A (en) Process for producing new 3-alkenyl-1-azabicyclo/3.2.0/ hept-2-ene-2-carboxylic acid derivatives and pharmaceutical compositions comprising same
EP0386675A3 (en) Xanthine derivatives
CA2386813A1 (en) Bicyclic imidazo-3-yl amine derivatives substituted on the 6-membered ring
IE780515L (en) Morphine derivatives
CA2124455A1 (en) Indole derivatives, process for producing the same and medicinal uses of the same
RU92016595A (ru) Замещенные тиазолильные и замещенные пиридинильные производные, фармацевтическая композиция и способ их получения
GEP19971030B (en) Method for preparation of derivatives of 1-benzil-3-oximetil-indazolului or salts with pharmaceutically acceptable bases
TW221441B (zh)
ATE261425T1 (de) Erythromycin-derivate mit antibiotischer wirkung
SE9300758D0 (sv) Process for the production of clavulanic acid
HUT50334A (en) Process for producing arylpiperazinyl-alkilenephenyl-p-heterocycluc compounds, pharmaceutically acceptable acid addition salts thereof and pharmaceutical compositions comprising the compounds as active ingredient
EE9400296A (et) Piperidinüültioindooli derivaadid, ravimvormid, aktiivne valuvaigisti, nende valmistamise meetodid
WO1999004770A3 (en) A pharmaceutical composition active in reducing production of mcp-1 protein
EP0302967A3 (en) Quinazoline derivative, processes for its production, and cerebral dysfunction remedying agent comprising it as active ingredient
HU9300202D0 (en) Benzo-pyrane derivatives, pharmaceutical preparatives containing them as active substance as well as method for producing them
CA2256007A1 (en) Substituted heterocyclic benzocycloalkenes and their use as analgesic
PT855398E (pt) Derivados sasquiterpeno tendo actividade antiviral
TW347383B (en) A process for the production of a crystalline sodium salt of amoxicillin in ethanol as solvent

Legal Events

Date Code Title Description
MK4A Expiration of patent term of an invention patent